5-Bromo-4-chloro-3-indolyl β-D-ribofuranoside

• Catalog No.: 44687
• CAS Number: 518033-33-5
• M. F.: C13H13BrClNO5
• M. W.: 378.60302
• Purity: ≥98.0% (HPLC)

SYNONYMS

• IUPAC name: (2S,3R,4S,5R)-2-[(5-bromo-4-chloro-1H-indol-3-yl)oxy]-5-(hydroxymethyl)oxolane-3,4-diol
• IUPAC Traditional name: (2S,3R,4S,5R)-2-[(5-bromo-4-chloro-1H-indol-3-yl)oxy]-5-(hydroxymethyl)oxolane-3,4-diol
• Synonyms: X β-D-ribofuranoside; X-riboside

DATABASE IDS

• MDL Number: MFCD06796946
• CAS Number: 518033-33-5

PROPERTIES

• Empirical Formula (Hill Notation): C13H13BrClNO5
• Purity: ≥98.0% (HPLC)
• Optical Rotation: [α]/D -102.0±3.0°, c = 1 in methanol
• Personal Protective Equipment: Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter
• Storage Temperature: -20°C
• German water hazard class: 3

DETAILS

Description (English)

Application
Evaluation of novel beta-ribosidase substrates for the differentiation of Gram-negative bacteria1
Legal Information
Supplied by Glycosynth Limited, U.S. Patent No. 7,323,488, European Patent Nos. 1436411 and 1438424, for use only in internal research conducted by the purchaser. No rights under the aforementioned patents are conveyed which permit the resale, transfer, or use for purposes other than research. Rights under the aforementioned patents, for purposes other than internal research, may be obtained by contacting Glycosynth Limited.

Description (简体中文)

Application
Evaluation of novel beta-ribosidase substrates for the differentiation of Gram-negative bacteria1
Legal Information
Supplied by Glycosynth Limited, U.S. Patent No. 7,323,488, European Patent Nos. 1436411 and 1438424, for use only in internal research conducted by the purchaser. No rights under the aforementioned patents are conveyed which permit the resale, transfer, or use for purposes other than research. Rights under the aforementioned patents, for purposes other than internal research, may be obtained by contacting Glycosynth Limited.